Which statement about bradycardia management is true?

• A. Atropine is effective for all high-degree blocks
• B. Pacing speed 140 beats per minute
• C. Transcutaneous pacing is never indicated
• D. The maximum pacing rate is 100 beats per minute

Answer: (D)

Bradycardia management hinges on keeping enough cardiac output to perfuse vital organs while addressing why the heart is beating slowly. For symptomatic bradycardia, you first consider medications that improve conduction, but their effectiveness depends on where the block is.

Atropine can help when the slowdown is due to nodal (AV nodal) slowing, but it isn’t effective for all high-degree blocks, especially if the block lies below the AV node. In those situations, relying on atropine alone won’t restore a safe heart rate, so pacing becomes necessary to provide a reliable rate and maintain perfusion.

Pacing, often starting with transcutaneous (external) pads, is used to bridge to a more definitive solution if drugs don’t produce adequate rate or if a high-degree AV block is present. It’s not something you use never; it’s indicated when pacing is the fastest way to stabilize a patient with symptomatic bradycardia or ongoing hemodynamic compromise.

When setting pacing, the goal is to restore perfusion without pushing the heart into tachycardia. The upper limit used for temporary external pacing is typically around 100 beats per minute. Rates higher than that increase myocardial oxygen demand and can worsen instability, so 100 bpm serves as a safe ceiling while you monitor response and adjust as needed. If pacing at 100 bpm isn’t enough, clinicians escalate to transvenous pacing or adjust pharmacologic support as appropriate.

So, the statement about the maximum pacing rate being 100 bpm reflects the balance between achieving an adequate rate and avoiding the risks of tachycardia.